Lion Corp
TSE:4912
Lion Corp
TSE:4912
Price:
1 787.5
JPY
-1.68%
Market Cap:
494B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Lion Corp
1787.5
-30.5 (-1.68%)
| 52 Week Range |
1 206
1 870.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Lion Corp
Balance Sheet
Balance Sheet Decomposition
Lion Corp
Lion Corp
| Current Assets | 215.7B |
| Cash & Short-Term Investments | 85.7B |
| Receivables | 66.8B |
| Other Current Assets | 63.2B |
| Non-Current Assets | 245.1B |
| Long-Term Investments | 49.5B |
| PP&E | 157.1B |
| Intangibles | 22B |
| Other Non-Current Assets | 16.5B |
| Current Liabilities | 121.8B |
| Accounts Payable | 98.2B |
| Other Current Liabilities | 23.6B |
| Non-Current Liabilities | 58.6B |
| Long-Term Debt | 29.8B |
| Other Non-Current Liabilities | 28.7B |
Balance Sheet
Lion Corp
Lion Corp
Currency: JPY
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
18 008
|
18 584
|
17 879
|
22 190
|
38 504
|
74 818
|
120 013
|
94 277
|
98 797
|
85 526
|
|
| Cash Equivalents |
18 008
|
18 584
|
17 879
|
22 190
|
38 504
|
74 818
|
120 013
|
94 277
|
98 797
|
85 526
|
|
| Short-Term Investments |
24 448
|
45 919
|
61 007
|
71 207
|
69 050
|
39 612
|
10 113
|
9 629
|
10 258
|
14 931
|
|
| Total Receivables |
58 956
|
58 557
|
60 229
|
64 871
|
64 695
|
61 759
|
62 421
|
70 115
|
71 263
|
75 230
|
|
| Accounts Receivables |
58 956
|
58 557
|
60 229
|
64 871
|
64 695
|
61 759
|
62 421
|
70 115
|
71 263
|
75 230
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
39 364
|
37 553
|
39 725
|
39 654
|
42 057
|
43 555
|
45 158
|
51 714
|
53 909
|
56 090
|
|
| Other Current Assets |
5 399
|
6 217
|
6 629
|
1 598
|
1 628
|
2 753
|
7 714
|
6 415
|
3 464
|
3 152
|
|
| Total Current Assets |
146 175
|
166 830
|
185 469
|
199 520
|
215 934
|
222 497
|
245 419
|
232 150
|
237 691
|
232 274
|
|
| PP&E Net |
79 275
|
75 060
|
74 402
|
79 539
|
81 546
|
96 843
|
123 252
|
126 089
|
161 655
|
171 984
|
|
| PP&E Gross |
79 275
|
75 060
|
74 402
|
79 539
|
81 546
|
96 843
|
123 252
|
126 089
|
161 655
|
171 984
|
|
| Accumulated Depreciation |
185 162
|
184 796
|
171 889
|
176 441
|
175 100
|
182 124
|
189 361
|
198 667
|
210 313
|
218 301
|
|
| Intangible Assets |
8 761
|
5 658
|
2 640
|
8 149
|
10 160
|
13 485
|
18 921
|
23 975
|
23 917
|
22 712
|
|
| Goodwill |
345
|
263
|
182
|
182
|
182
|
182
|
182
|
182
|
327
|
327
|
|
| Note Receivable |
0
|
30
|
28
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
34 438
|
21 116
|
24 025
|
34 984
|
33 703
|
34 682
|
31 169
|
28 750
|
31 795
|
42 962
|
|
| Other Long-Term Assets |
14 335
|
13 477
|
11 764
|
16 481
|
13 840
|
13 012
|
16 558
|
16 879
|
13 893
|
16 104
|
|
| Other Assets |
345
|
263
|
182
|
182
|
182
|
182
|
182
|
182
|
327
|
327
|
|
| Total Assets |
283 352
N/A
|
282 434
0%
|
298 510
+6%
|
338 855
+14%
|
355 365
+5%
|
380 701
+7%
|
435 501
+14%
|
428 025
-2%
|
469 278
+10%
|
486 363
+4%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
46 590
|
49 620
|
50 947
|
61 711
|
67 107
|
64 716
|
74 668
|
71 577
|
74 166
|
198 310
|
|
| Accrued Liabilities |
2 887
|
3 328
|
4 179
|
49 998
|
49 873
|
51 552
|
66 591
|
51 569
|
51 858
|
54 006
|
|
| Short-Term Debt |
12 602
|
9 772
|
4 244
|
3 754
|
1 150
|
1 150
|
1 150
|
1 150
|
1 150
|
0
|
|
| Current Portion of Long-Term Debt |
116
|
226
|
260
|
286
|
509
|
1 749
|
1 642
|
1 744
|
2 029
|
2 191
|
|
| Other Current Liabilities |
53 342
|
58 301
|
63 810
|
13 651
|
11 103
|
16 551
|
22 577
|
13 178
|
12 371
|
14 984
|
|
| Total Current Liabilities |
115 537
|
121 247
|
123 440
|
129 400
|
129 742
|
135 718
|
166 628
|
139 218
|
141 574
|
143 333
|
|
| Long-Term Debt |
19 501
|
7 181
|
4 415
|
1 569
|
1 491
|
6 399
|
5 324
|
5 480
|
28 990
|
28 150
|
|
| Deferred Income Tax |
0
|
0
|
0
|
6 440
|
4 232
|
873
|
1 278
|
1 270
|
2 701
|
5 847
|
|
| Minority Interest |
5 888
|
7 873
|
8 377
|
10 353
|
13 163
|
12 780
|
13 133
|
13 442
|
14 912
|
17 817
|
|
| Other Liabilities |
20 880
|
11 276
|
12 776
|
12 653
|
15 629
|
16 510
|
17 415
|
17 043
|
16 845
|
10 899
|
|
| Total Liabilities |
161 806
N/A
|
147 577
-9%
|
149 008
+1%
|
160 415
+8%
|
164 257
+2%
|
172 280
+5%
|
203 778
+18%
|
176 453
-13%
|
205 022
+16%
|
206 046
+0%
|
|
| Equity | |||||||||||
| Common Stock |
34 433
|
34 433
|
34 433
|
34 433
|
34 433
|
34 433
|
34 433
|
34 433
|
34 433
|
34 433
|
|
| Retained Earnings |
67 005
|
69 817
|
82 697
|
98 835
|
115 971
|
132 762
|
157 103
|
177 505
|
192 965
|
204 305
|
|
| Additional Paid In Capital |
31 499
|
34 029
|
34 508
|
34 687
|
34 715
|
34 788
|
34 986
|
35 189
|
31 069
|
31 118
|
|
| Unrealized Security Profit/Loss |
7 912
|
5 983
|
7 429
|
13 826
|
10 800
|
11 289
|
10 592
|
8 541
|
8 930
|
10 227
|
|
| Treasury Stock |
16 827
|
6 800
|
4 778
|
4 805
|
4 766
|
4 739
|
4 739
|
4 731
|
8 056
|
7 868
|
|
| Other Equity |
2 476
|
2 605
|
4 787
|
1 464
|
45
|
112
|
652
|
635
|
4 915
|
8 102
|
|
| Total Equity |
121 546
N/A
|
134 857
+11%
|
149 502
+11%
|
178 440
+19%
|
191 108
+7%
|
208 421
+9%
|
231 723
+11%
|
251 572
+9%
|
264 256
+5%
|
280 317
+6%
|
|
| Total Liabilities & Equity |
283 352
N/A
|
282 434
0%
|
298 510
+6%
|
338 855
+14%
|
355 365
+5%
|
380 701
+7%
|
435 501
+14%
|
428 025
-2%
|
469 278
+10%
|
486 363
+4%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
268
|
287
|
291
|
291
|
291
|
291
|
291
|
291
|
284
|
284
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
